ASND Shariah Compliance

Screening Methodology: AAOIFI

lock image
UNLOCK FOR FREE

Last Updated: March 05, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Ascendis Pharma A/S (ASND)

Based on 24 analysts giving stock ratings to Ascendis Pharma A/S in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
46
Buy
50
Hold
4
Sell
0
Strong Sell
0
Ascendis Pharma A/S

Ascendis Pharma A/S. Stock Analysis ASND

United States Health Care Large Cap Report:
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. The firm produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The firm operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Read More

Ascendis Pharma A/S (ASND) Chart

Key Statistics of Ascendis Pharma A/S (ASND)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$226.06$231.50

Today's Open

$226.13

Volume

330.91K

P/E Ratio (TTM)

-

52 Week Range

$124.06$248.60

Market Cap

13.68B

Avg. Volume

740.89K

Dividend Yield

-

Financial Metrics & Statements of Ascendis Pharma A/S (ASND)

Super Investors Invested in Ascendis Pharma A/S (ASND)

Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.

FAQ's for Ascendis Pharma A/S (ASND)

  • According to Musaffa’s Shariah screening methodology, Ascendis Pharma A/S (ASND) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.